Northwestern University Feinberg School of Medicine

The Ken & Ruth Davee Department of Neurology

Clinical Trials

As part of an academic medical center, the Division of Neuromuscular Disease at Northwestern University Feinberg School of Medicine (Feinberg) aims to improve the human health through scientific research.

About Clinical Trials
Clinical trials test or study drugs, surgical procedures, medical devices, or interventions with human subjects. They look to determine their safety and effectiveness in relation to treating specific diseases. Clinical trials are part of clinical research and are at the heart of all medical advances.

Division of Neuromuscular Disease Clinical Trials
The following searchable list includes all the Division of Neuromuscular Disease clinical trials currently looking for participants.

Contact Us
Please feel free to contact us with inquiries about any of our ongoing research.

Trials
cIRB: Topiramate as a disease altering therapy for Cryptogenic Sensory Peripheral Neuropathy (CSPN)
This is a 96-week placebo-controlled trial of topiramate at a target dose of 100 mg daily (50 mg twice daily) as a potentially disease altering therapy for Cryptogenic Sensory Peripheral Neuropathy
INCLUSION: 1. Age 18-75; 2. Diagnosis of confirmed cryptogenic symptomatic distal symmetric peripheral polyneuropathy; 3. Prediabetes based on American Diabetes Association; 4. No history of prior therapy with topiramate; 5. Waist circumference >102 cm for men, >88 cm for women
Menichella, DanielaMenichella, Daniela
  • Map it 675 N. St. Clair St. Suite 20-100
    Chicago, IL
NCT02878798 STU00206049
More Info

For more information on this study please contact us:

Corado, Carlos 312 503 2778